ClinicalTrials.gg
Not yet recruitingNCT07521215IRISPORTUpdated Apr 9, 2026

Evaluation of Injury Risk Factors and Effects of Individualized Exercise Program in Basketball and Volleyball Athletes

An interventional study of Test-Specific Individualized Exercise Program in Athletic Injuries, Sports Injury Prevention and Musculoskeletal Injury, sponsored by Acibadem University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-09.

Sponsored by Acibadem University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Jun 2026, 5 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study aims to identify injury risk factors using a clinical/functional test battery in university basketball and volleyball athletes, to develop individualized exercise prescriptions for athletes scoring below established cut-off values on each test, and to evaluate the effects of an 8-week intervention program on test parameters.

As a secondary aim, all participants will be monitored prospectively over a 6-month season to assess the incidence of injuries and health problems, and to evaluate the contribution of the individualized program to injury-related health outcomes.

The study consists of four phases: (1) baseline cross-sectional assessment (T0), (2) 8-week individualized exercise intervention for athletes below cut-off thresholds, (3) post-intervention reassessment (T1), and (4) 6-month prospective injury surveillance (T2).

Read the detailed description

BACKGROUND:

Musculoskeletal injuries in athletes represent a significant sports medicine and public health problem due to restricted training/competition participation, prolonged rehabilitation, and increased re-injury risk. Epidemiological data indicate that basketball and volleyball athletes carry elevated risk for lower extremity sprains/strains, knee ligament injuries, and overhead-related shoulder pathologies. University athletes are particularly vulnerable given the concurrent demands of intense academic schedules and high training loads.

Clinical/functional tests can systematically identify modifiable risk factors including neuromuscular control, balance, flexibility, and functional strength. The Y-Balance Test (YBT-LQ), Hop-for-Distance Test (Limb Symmetry Index), Active Straight Leg Raise (ASLR), Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST), and Glenohumeral Internal Rotation Deficit (GIRD) assessment are employed in this study, each with established reliability and predictive validity.

STUDY DESIGN:

This is a non-randomized, parallel-group interventional study. Athletes scoring below literature-defined cut-off values on any test receive test-specific individualized exercise prescriptions (Intervention Group), while athletes meeting all cut-off thresholds receive no intervention and serve as the observation group. Both groups undergo identical assessment at T0 and T1, and are monitored for injuries through T2.

INTERVENTION:

The 8-week individualized exercise program is prescribed based on each athlete's specific deficits:

  • YBT-LQ below cut-off (composite score less than 94% or asymmetry greater than 4 cm): Dynamic balance and proprioception exercises
  • Hop Test LSI below 90%: Plyometric control and symmetry exercises
  • ASLR below 70 degrees: Hamstring/posterior chain flexibility exercises
  • CKCUEST below cut-off (males less than 21, females less than 23 touches): Scapular stability and upper extremity endurance exercises
  • GIRD above cut-off (internal rotation deficit greater than 20 degrees or total rotation difference greater than 5 degrees): Posterior shoulder capsule and rotator cuff exercises

Frequency: 3 days/week, 20-30 minutes per session. First 2 weeks supervised, subsequent weeks partially independent. Weekly compliance logged.

INJURY SURVEILLANCE (T2):

All participants are monitored for 6 months using IOC 2020 Consensus Statement methodology. Events are classified by type (injury/illness), onset (acute/overuse), anatomical region, severity (time-loss days), and recurrence status. Participant reports are cross-checked with team staff records where available.

STATISTICAL ANALYSIS:

Descriptive statistics (mean +/- SD, median, frequencies). T0-T1 comparisons: paired t-test or Wilcoxon signed-rank test (only athletes below cut-off for each respective test). Between-branch comparisons: independent t-test / Mann-Whitney U, chi-square / Fisher exact test. Effect sizes (Cohen's d). Injury incidence comparison between intervention and observation groups at T2. Significance level: p less than 0.05.

02

Conditions studied

  • Athletic Injuries
  • Sports Injury Prevention
  • Musculoskeletal Injury

Browse trials for

Keywords

  • injury prevention
  • individualized exercise
  • Y-Balance Test
  • Hop Test
  • Limb Symmetry Index
  • GIRD
  • CKCUEST
  • university athletes
  • basketball
  • volleyball
  • functional screening
  • neuromuscular training
03

In context

Athletic Injuries

258 studies on the registry are indexed under Athletic Injuries; 45 are open to participants now.

This study's planned enrollment of 100 is above the median of 44 across 164 interventional studies indexed under Athletic Injuries.

Browse Athletic Injuries studies →

Lead sponsor

Acibadem University is the lead sponsor of 220 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Active member of Acibadem University basketball or volleyball team
  • Regular training within the past 6 months
  • Age 18 years or older
  • Willing to participate and provide written
  • Physical and cognitive capacity to complete test protocols

Exclusion criteria

Exclusion Criteria:

  • Surgical intervention within the past 6 months
  • Acute musculoskeletal injury within the past 2 weeks (acute sprain/strain/contusion etc.) that would preclude testing
  • History of vestibular disorder, neurological disease, or systemic condition that may affect balance testing
  • Uncontrolled cardiovascular disease/hypertension or other medical condition contraindicating exercise
  • Pregnancy or within the first 6 months postpartum (female athletes)
  • Refusal to provide
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Individualized Exercise Intervention

    Athletes scoring below established literature cut-off values on one or more clinical/functional tests at baseline (T0). Each athlete receives a test-specific individualized exercise prescription targeting their identified deficits. The program is administered 3 days/week for 8 weeks (20-30 min/session), with supervised sessions in weeks 1-2 and partially independent sessions in weeks 3-8.

    Behavioral: Test-Specific Individualized Exercise Program

  • No intervention
    Observation (No Intervention)

    Athletes meeting all literature-defined cut-off thresholds on every clinical/functional test at baseline (T0). These athletes continue their routine training without additional exercise intervention. They undergo the same T0 and T1 assessments and 6-month injury surveillance as the intervention group.

Interventions

  • BehavioralTest-Specific Individualized Exercise Program

    An 8-week individualized exercise program prescribed based on each athlete's baseline test deficits. Components include: 1. Dynamic balance/proprioception exercises (for YBT-LQ deficit): single-leg balance progressions, 3-direction reach drills, BOSU balance exercises. 2. Plyometric control and symmetry exercises (for Hop Test LSI deficit): single-leg hop-and-stick, lateral hops, eccentric step-up/step-down. 3. Hamstring/posterior chain flexibility exercises (for ASLR deficit): static hamstring stretching with strap, PNF contract-relax, seated hamstring stretch. 4. Scapular stability and upper extremity endurance exercises (for CKCUEST deficit): plank shoulder taps, bear crawl, side plank progressions. 5. Posterior shoulder capsule and rotator cuff exercises (for GIRD deficit): cross-body stretch, sleeper stretch, external rotation with resistance band. Dosage: 3 sessions/week, 20-30 minutes/session. Progressive overload applied. Weekly compliance monitored.

06

What researchers measure

Primary outcomes

  1. Change in Y-Balance Test Lower Quarter (YBT-LQ) Composite Score

    Composite score calculated as \[(Anterior + Posteromedial + Posterolateral) / (3 x Leg Length)\] x 100. Assessed bilaterally. Cut-off: composite score less than 94% or right-left asymmetry greater than 4 cm.

    Time frame: Baseline (T0) and 8 weeks (T1)

  2. Change in Hop-for-Distance Test Limb Symmetry Index (LSI)

    LSI calculated as (Weaker Side / Stronger Side) x 100. Three trials per limb, best distance recorded. Cut-off: LSI less than 90%.

    Time frame: Baseline (T0) and 8 weeks (T1)

  3. Change in Active Straight Leg Raise (ASLR) Hip Flexion Angle

    Hip flexion range of motion measured by goniometry in supine position with knee extended. Two measurements per limb, average recorded. Cut-off: hip flexion less than 70 degrees.

    Time frame: Baseline (T0) and 8 weeks (T1)

  4. Change in Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST) Score

    Number of hand touches in 15 seconds from push-up position with hands 91 cm apart. Three trials, best score recorded. Cut-off: males less than 21 touches, females less than 23 touches.

    Time frame: Baseline (T0) and 8 weeks (T1)

  5. Change in Glenohumeral Internal Rotation Deficit (GIRD)

    Internal and external rotation measured by goniometry in supine (shoulder 90 degrees abduction, elbow 90 degrees flexion), scapula stabilized. GIRD = non-dominant IR minus dominant IR. Cut-off: IR deficit greater than 20 degrees or total rotation difference greater than 5 degrees.

    Time frame: Baseline (T0) and 8 weeks (T1)

Secondary outcomes

  1. Incidence of Musculoskeletal Injuries and Health Problems

    Prospective injury surveillance using IOC 2020 Consensus Statement methodology. Events classified by type (injury/illness), onset (acute/overuse), anatomical region, severity (time-loss: 0, 1-3, 4-7, 8-28, greater than 28 days), and recurrence. Comparison between intervention and observation groups.

    Time frame: 6 months (T0 through T2)

  2. Pittsburgh Sleep Quality Index (PSQI) Global Score

    Self-report measure of sleep quality over the past month. 19 items, 7 components, global score 0-21. Higher scores indicate poorer sleep quality. Global PSQI greater than 5 indicates clinically significant poor sleep quality.

    Time frame: Baseline (T0)

  3. Borg Rating of Perceived Exertion (RPE)

    Perceived exertion level assessed using the Borg RPE Scale (6-20).

    Time frame: Baseline (T0)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07521215
Responsible party
Ali Ömer Acar (Lecturer, Department of Physiotherapy and Rehabilitation, Acibadem University) — Principal investigator
First posted
Apr 9, 2026
Start date
Apr 2026 (estimated)
Primary completion
Jun 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Apr 9, 2026

Study contacts

Ali Omer Acar
Contact
aliomer.acar@acibadem.edu.tr
+905378262790
Selcuk Marangoz
Contact
selcuk.marangoz@acibadem.edu.tr
+905355775928
Ali Omer Acar
principal investigator · Acibadem Mehmet Ali Aydinlar University, Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion